AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress 
p53-driven apoptosis

Höpker, Katja; Hagmann, Henning; Khurshid, Safiya; Chen, Shuhua; Hasskamp, Pia; Seeger-Nukpezah, Tamina; Schilberg, Katharina; Heukamp, Lukas; Lamkemeyer, Tobias; Sos, Martin L.; Thomas, Roman K.; Lowery, Drew; Roels, Frederik; Fischer, Matthias; Liebau, Max C.; Resch, Ulrike; Kisner, Tülay; Röther, Fabian; Bartram, Malte P.; Müller, Roman Ulrich; Fabretti, Francesca; Kurschat, Peter; Schumacher, Björn; Gaestel, Matthias; Medema, Rene H.; Yaffe, Michael B.; Schermer, Bernhard; Reinhard, H. Christian; Benzing, Thomas

doi:10.1038/emboj.2012.236

Local TagsRelease HistoryDetailsSummary

AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis

Höpker, K., Hagmann, H., Khurshid, S., Chen, S., Hasskamp, P., Seeger-Nukpezah, T., et al. (2012). AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis. EMBO Journal, 31(20), 3961-3975. doi:10.1038/emboj.2012.236.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-D1CE-D Version Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-D1CF-B

Genre: Journal Article

Files

show Files

Locators

show

Creators

show

hide

Creators:
Höpker, Katja¹, Author
Hagmann, Henning¹, Author
Khurshid, Safiya¹, Author
Chen, Shuhua², Author
Hasskamp, Pia¹, Author
Seeger-Nukpezah, Tamina¹, Author
Schilberg, Katharina¹, Author
Heukamp, Lukas¹, Author
Lamkemeyer, Tobias¹, Author
Sos, Martin L.², Author
Thomas, Roman K.², Author
Lowery, Drew¹, Author
Roels, Frederik¹, Author
Fischer, Matthias¹, Author
Liebau, Max C.¹, Author
Resch, Ulrike¹, Author
Kisner, Tülay¹, Author
Röther, Fabian¹, Author
Bartram, Malte P.¹, Author
Müller, Roman Ulrich¹, Author
Fabretti, Francesca¹, AuthorKurschat, Peter¹, AuthorSchumacher, Björn¹, AuthorGaestel, Matthias¹, AuthorMedema, Rene H.¹, AuthorYaffe, Michael B.¹, AuthorSchermer, Bernhard¹, AuthorReinhard, H. Christian¹, AuthorBenzing, Thomas¹, Author more..

Affiliations:
1a Department II of Internal Medicine, University Hospital of Cologne, Cologne, Germany b 1] Department II of Internal Medicine, University Hospital of Cologne, Cologne, Germany c Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany d 1] Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany e Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany f Institute of Pathology, University of Cologne, Cologne, Germany g 1] Max Planck Institute for Neurological Research with Klaus-Joachim-Züls-Laboratories of the Max Planck Society and the Medical Faculty of the University of Cologne, Cologne, Germany h Department of Translational Genomics, University of Cologne, Cologne, Germany i Howard Hughes Medical Institute, Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA j 1] Institute of Pathology, University of Cologne, Cologne, Germany k Massachusetts Institute of Technology, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA l Department of Pediatrics, University Hospital of Cologne, Cologne, Germany m 1] Department of Pediatrics, University Hospital of Cologne, Cologne, Germany n Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany o Department of Dermatology, University Hospital of Cologne, Cologne, Germany p Systems Biology of Aging, University of Cologne, Cologne, Germany q Institute of Physiological Chemistry, Hannover Medical University, Hannover, Germany r Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands, ou_persistent22
2Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656

Content

show

Details

show

hide

Language(s): eng - English

Dates: Date issued: 2012

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: Peer

Identifiers: eDoc: 614877
DOI: 10.1038/emboj.2012.236

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: EMBO Journal

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: -

Pages: - Volume / Issue: 31 (20) Sequence Number: - Start / End Page: 3961 - 3975 Identifier: ISSN: 02614189